文献速递泌尿生殖儿科影像PETCT

18F-氟脱氧葡萄糖正电子发射断层显像/计算机断层显像鉴别儿童肾透明细胞肉瘤与Wilms瘤

18F-Fluorodeoxyglucose positron emission tomography/computed tomography in distinguishing pediatric clear cell sarcoma of the kidney from Wilms' tumor.
PubMed 文献 · Pediatr Radiol · 2025-05-05

本研究为可行性研究,纳入19例肾透明细胞肉瘤和84例Wilms瘤患儿,其中11/19例肾透明细胞肉瘤和28/84例Wilms瘤在18F-FDG PET/CT上显示阳性病灶并经组织学、常规影像或临床随访证实。回顾性分析显示肾透明细胞肉瘤所有病灶的平均SUVmax显著低于Wilms瘤(3.9 vs. 7.4;P<0.001),ROC曲线确定SUVmax cutoff为4.3时鉴别诊断的敏感度为75.0%、特异度为87.5%。

要点

  • 肾透明细胞肉瘤所有病灶平均SUVmax为3.9,显著低于Wilms瘤的7.4(P<0.001)。
  • 原发灶SUVmax肾透明细胞肉瘤3.6 vs. Wilms瘤6.6(P=0.042),转移灶4.0 vs. 7.8(P=0.011)。
  • SUVmax cutoff 4.3支持肾透明细胞肉瘤诊断,敏感度75.0%、特异度87.5%。

核心结论

  • 肾透明细胞肉瘤在18F-FDG PET/CT上的SUVmax显著低于Wilms瘤,提出的阈值SUVmax 4.3可作为鉴别两者的有效标准,18F-FDG PET/CT在区分大肾肿块病例中的肾透明细胞肉瘤与Wilms瘤方面显示出潜力。

研究设计与样本

  • 可行性研究,回顾性分析19例肾透明细胞肉瘤和84例Wilms瘤患者,其中11/19例肾透明细胞肉瘤和28/84例Wilms瘤在18F-FDG PET/CT上显示阳性病灶并经组织学检查、常规影像或临床随访证实为肿瘤病灶,采用ROC曲线分析确定SUVmax最佳cutoff。

关键影像表现/征象

  • 肾透明细胞肉瘤所有病灶的平均SUVmax为3.9,显著低于Wilms瘤的7.4(P<0.001)。
  • 肾透明细胞肉瘤原发灶SUVmax为3.6,低于Wilms瘤的6.6(P=0.042)。
  • 肾透明细胞肉瘤转移灶SUVmax为4.0,低于Wilms瘤的7.8(P=0.011)。

诊断标准与关键数值

  • ROC曲线分析显示SUVmax cutoff为4.3时有效支持肾透明细胞肉瘤而非Wilms瘤的诊断,敏感度75.0%、特异度87.5%。

临床应用与阅片要点

  • 在18F-FDG PET/CT上,肾透明细胞肉瘤病灶的SUVmax低于Wilms瘤,可参考SUVmax 4.3作为鉴别两者的阈值。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Clear cell sarcoma of the kidney is a rare primary renal malignancy in children and its differentiation from other renal tumors, particularly Wilms' tumor, poses significant diagnostic challenges. Notably, clear cell sarcoma of the kidney is associated with a poorer prognosis than Wilms' tumor, making the preoperative presumptive diagnosis critical for optimizing surgical resection and appropriate chemotherapy regimens.

OBJECTIVE: We conducted a feasibility study to evaluate the diagnostic utility of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in distinguishing clear cell sarcoma of the kidney from Wilms' tumor.

MATERIALS AND METHODS: This study included 19 patients diagnosed with clear cell sarcoma of the kidney and 84 patients with Wilms' tumor. Among these, 11/19 patients with clear cell sarcoma of the kidney and 28/84 patients of Wilms' tumor displayed positive findings on 18F-FDG PET/CT imaging, which were subsequently validated as tumor lesions by histologic examination, conventional imaging, or clinical follow-up. A retrospective analysis of the imaging features of clear cell sarcoma of the kidney and Wilms' tumor lesions on 18F-FDG PET/CT scans was conducted. Receiver operating characteristic (ROC) curve analyses were performed to determine the optimal cutoff of the maximum standardized uptake value (SUVmax) for diagnostic prediction.

RESULTS: The mean SUVmax for all lesions of clear cell sarcoma of the kidney was significantly lower than that of Wilms' tumors (3.9 vs. 7.4; P<0.001). When analyzed separately, primary lesions (3.6 vs. 6.6; P=0.042) and metastatic lesions (4.0 vs. 7.8; P=0.011) both had lower SUVmax in clear cell sarcomas of the kidney compared with Wilms' tumors. ROC curve analysis revealed a cutoff SUVmax of 4.3, which effectively supported the diagnosis of clear cell sarcoma of the kidney over Wilms' tumor, with a sensitivity of 75.0% and a specificity of 87.5%.

CONCLUSIONS: Clear cell sarcomas of the kidney exhibited a significantly lower SUVmax on 18F-FDG PET/CT when compared to Wilms' tumor lesions, with a proposed threshold SUVmax of 4.3 serving as an effective criterion for differentiation. Consequently, 18F-FDG PET/CT demonstrated potential in distinguishing clear cell sarcoma of the kidney from Wilms' tumor in cases involving large renal masses.

来源:Pediatr Radiol,查看原文。版权归原作者所有。

引用

  1. Sun H, Yang Z, Jin H, et al. 18F-Fluorodeoxyglucose positron emission tomography/computed tomography in distinguishing pediatric clear cell sarcoma of the kidney from Wilms' tumor. Pediatr Radiol. 2025. PMID: 40323439. doi:10.1007/s00247-025-06239-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。